Accident and Emergency Departments: East of England
Andy Sawford: To ask the Secretary of State for Health what the average waiting times are at each individual accident and emergency unit in East Anglia. [154178]
Anna Soubry: The information requested is not available in the format requested. However, the following table shows the average waiting times in accident and emergency (A&E) for national health services trusts in the former East of England strategic health authority area.
15 May 2013 : Column 295W
Accident and Emergency Departments: Kettering
Andy Sawford: To ask the Secretary of State for Health how many patients have waited more than four hours in accident and emergency at Kettering General Hospital in each month since May 2010. [154176]
Anna Soubry: The information requested is provided in the following table.
| Accident and emergency attendances with total time over four hours at Kettering General Hospitals NHS Foundation Trust by month, May 2010 to present | |||
| Number of over four hour waits | Number of weeks in month | ||
| (1) Calendar month. Note: Figures from weekly returns assigned months and hence do not represent a calendar month apart from August to October 2010. Source: Weekly situation reports, monthly situation reports (August to October 2010 only). | |||
15 May 2013 : Column 296W
Andy Sawford: To ask the Secretary of State for Health how many patients have used accident and emergency at Kettering General Hospital in each of the last five years; and what estimate he has made of demand for the service in each of the next five years. [154179]
Anna Soubry: The information requested is provided in the following table. Local national health service commissioners and providers are responsible for service planning to ensure that the local NHS continues to meet the needs of local communities.
| Accident and emergency (A&E) attendances at Kettering General Hospitals NHS Trust | ||
| Number of attendances | ||
| Type 1 (major) A&E | All types | |
| Source: QMAE quarterly return, weekly situation reports (11-12 onwards) | ||
Andy Sawford: To ask the Secretary of State for Health how many times Kettering General Hospital has issued public statements in which it urged people not to come to accident and emergency in each of the last five years. [154624]
Anna Soubry: The information requested is not held centrally.
Accident and Emergency Departments: North West
Helen Jones: To ask the Secretary of State for Health on how many occasions the accident and emergency waiting time target has been breached in each hospital in the North West in the last 26 weeks for which information is available. [155221]
Anna Soubry: The information is not held in the format requested. The number of times the accident and emergency (A&E) waiting time standard (95% within four hours) has been missed in the last 26 weeks (11 November 2012 to 5 May 2013) for each NHS trust in the north-west is shown in the following table:
| NHS trust | Number of times the A&E standard was missed in the last 26 weeks |
|
Central Manchester University Hospitals NHS Foundation Trust | |
15 May 2013 : Column 297W
|
University Hospital of South Manchester NHS Foundation Trust | |
15 May 2013 : Column 298W
| Note: A&E data are not held at hospital site level so data for the relevant hospital trust have been provided. Source: NHS England Unify2 Data Collection Weekly SiteRep | |
Anaemia
Cathy Jamieson: To ask the Secretary of State for Health what recent discussions he has had with the Cabinet Secretary for Health in Scotland regarding the incidence of aplastic anaemia with idiopathic causes. [154424]
Anna Soubry: The Secretary of State for Health, and departmental officials have had no such discussions.
Buildings
John Mann: To ask the Secretary of State for Health what the total running costs were for each building used, owned or rented in central London by his Department, its agencies and non-departmental public bodies, other than for buildings primarily used for the provision of medical services, in each of the last three financial years. [154242]
Anna Soubry: The total running costs for each building used, owned or rented in central London by the Department, its agencies and non-departmental public bodies, are identified in the following table.
| £ | ||||
| Building | Occupancy | 2010-11 | 2011-12 | 2012-13 |
15 May 2013 : Column 299W
15 May 2013 : Column 300W
| (1) Costs exclude the charges made by the Department for collocation and other organisations occupancy in departmental buildings. (2) The charge by the Department for occupancy in departmental buildings based on a percentage of departmental running costs. These are NHS organisations and not departmental agencies or non-departmental public bodies (3) NICE moved from Mid-City Place in December 2012 to Spring Gardens and the costs for 2012-13 include the costs for Spring Gardens. Notes: 1. Central London has been defined as the following postcode areas, SW1, W1, WC1, WC2 and SE1. 2. The Department and its arm's length bodies aim to maximise the occupancy, of its estate in line with the national Property Controls. Wherever possible we encourage collocation and sharing of buildings. 3. The Department and its arm's length bodies aim to maximise the occupancy of its estate with in line with the national Property Controls. Wherever possible we encourage collocation and sharing of buildings. | ||||
Cancer
Ms Abbott: To ask the Secretary of State for Health which NHS bodies are responsible for ensuring that the guidance on the management of low-risk basal cell carcinomas in the community published by NICE in 2011 is safely implemented. [154677]
Anna Soubry: The National Institute of Health and Care Excellence's cancer service guidance is not mandatory. It represents evidence-based best practice and we would expect national health service organisations to take it fully into account as they design services to meet the needs of patients. It is for NHS organisations to consider how best to implement the guidance safety.
Pauline Latham: To ask the Secretary of State for Health whether his Department has allocated funding to treat newly-diagnosed NHS cancer patients who cannot access previously reimbursed cancer treatments following the transition of the Cancer Drugs Fund on 1 April 2013. [154912]
Norman Lamb: £200 million has been made available to the national health service in 2013-14 for the Cancer Drugs Fund.
Cancer: Clinical Commissioning Groups
Mr Clappison: To ask the Secretary of State for Health (1) what steps he plans to take to support clinical commissioning groups to improve the experience of cancer patients in their area; [154628]
(2) what steps he is taking to address variations of care reported in the National Cancer Patient Experience survey. [154629]
Anna Soubry: The Mandate to NHS England requires it to deliver continued improvements in relation to patients' experience of care, including cancer care.
The national report and 160 bespoke trust level reports from the National Cancer Patient Experience Survey 2011-12, published in August 2012, continue to support both clinical commissioning groups (CCGs) and providers to drive and inform local service improvement. The trust level reports provide benchmarked data nationally and between teams, allowing providers to identify priority improvement areas and supporting CCGs to better commission high quality cancer services for local populations.
15 May 2013 : Column 301W
Work on the National Cancer Patient Experience Survey 2012-13 is currently under way. It is anticipated that national and trust level reports will be published in summer 2013.
More generally, NHS Improving Quality (NHS IQ), the new NHS Improvement body, has made “ensuring that experience of care is central to commissioning and care delivery” one of its 10 key work programmes for 2013-14. NHS IQ will be working on the design and testing of an improvement framework for engaging, involving and improving experience of care; a capability building programme for commissioners and providers; and specific interventions to improve experience, such as the friends and family test.
Coeliac Disease
Katy Clark: To ask the Secretary of State for Health what steps his Department is taking to improve the diagnosis of coeliac disease. [154411]
Norman Lamb: Clinical commissioning groups, as local commissioners have the primary responsibility for determining what steps are needed to improve the diagnosis of people with coeliac disease in their area.
To support local commissioners, the National Institute for Health and Care Excellence (NICE) has published a clinical guideline ‘Coeliac Disease: Recognition and Assessment of Coeliac Disease’ to help improve the recognition of coeliac disease and increase the number of people diagnosed with the condition.
Katy Clark: To ask the Secretary of State for Health what steps his Department is taking to mark Coeliac Awareness Week. [154412]
Norman Lamb: Clinical commissioning groups are now responsible for commissioning services for people with coeliac disease.
The Government recognise the importance of the disease and will continue to work with NHS England to drive improvements in the quality of services.
Defibrillators
Chris Ruane: To ask the Secretary of State for Health (1) what proportion of ambulance vehicles were equipped with defibrillators in each of the last 30 years; [154787]
(2) what assessment he has made of the availability and accessibility of defibrillators on survival rates for out-of-hospital cardiac arrests; [154806]
(3) what funding his Department has made available for the (a) purchase of defibrillators and (b) training of members of the public in their use. [154807]
Anna Soubry: Information on the proportion of ambulances equipped with defibrillators is not collected centrally.
The Department has made no assessment of the availability and accessibility of defibrillators on survival rates for out of hospital cardiac arrests.
The Department does not currently fund the purchase of defibrillators or the training of members of the public in the use of defibrillators. Ambulance trusts have had responsibility for sustaining the legacy of the National Defibrillator Programme since February 2007.
15 May 2013 : Column 302W
Drugs
Kate Green: To ask the Secretary of State for Health what recent assessment he has made of the adequacy of supply of (a) loperamade and (b) trazodone; and if he will make a statement. [154207]
Norman Lamb: Departmental officials have been in touch with a number of suppliers of loperamide capsules who have indicated that they have good stocks available.
We are aware that there have been intermittent supply problems with trazodone. However, we understand that supplies have recently been released to the market with more expected later this month.
Drugs: Health Education
John Woodcock: To ask the Secretary of State for Health (1) what budget was available for public health education on the effects of legal highs in the last financial year; [155313]
(2) when he last reviewed the effectiveness of public health education and publicity on the effects of legal highs. [155314]
Anna Soubry: The FRANK drug information campaign provides young people and their families with advice and information about all drugs, including ‘legal highs’. The campaign is managed jointly by the Department of Health and the Home Office. We continually review the FRANK service to ensure that it provides effective and up to date information.
The Home Office funds advertising to raise awareness of the FRANK service. The Department has funded and managed the FRANK service which comprises the helpline, email, SMS, live chat and website and on 1 April this responsibility passed to Public Health England.
In 2012-13 the Department spent £0.9 million on the FRANK service. It is not possible to isolate the costs of providing information about legal highs. However in 2012, the Department launched a targeted campaign costing £21,000 to encourage parents to talk to their children about legal highs.
Electronic Cigarettes
Mr Frank Field: To ask the Secretary of State for Health if he will bring forward plans to restrict the marketing, sales and promotion of electronic cigarettes so that they (a) are only sold to adults at licensed outlets, (b) are only targeted at smokers as a way of reducing smoking or quitting and (c) do not appeal to non-smokers, particularly children. [154217]
Norman Lamb: There are a number of products on the market which claim to contain nicotine, such as electronic cigarettes, which are widely and easily available but are not licensed medicines. Currently, any nicotine containing product (NCP) that claims or implies that it can assist in giving up smoking is considered by the Medicines and Healthcare products Regulatory Agency (MHRA) to be a medicinal product. This approach has allowed NCPs which do not make such claims to be used and sold without the safeguards built into the regulation of medicines.
The Government are concerned to ensure that an effective, proportionate regulatory framework exists to protect consumers from any electronic cigarette products
15 May 2013 : Column 303W
that fail to meet acceptable standards for quality, safety and efficacy. The MHRA co-ordinated a programme of research to advise on:
an investigation of the levels of nicotine which have a significant physiological effect through its pharmacological action;
the nature, quality and safety of unlicensed NCPs;
the actual use of unlicensed NCPs (excluding tobacco products) in the marketplace;
the efficacy of unlicensed NCPs in smoking cessation; and
modelling of the potential impact of bringing these products into medicines regulation on public health outcomes.
The MHRA is currently bringing to a conclusion this period of scientific and market research with a view to a final decision on the application of medicines regulation soon.
Mr Frank Field: To ask the Secretary of State for Health if he will bring forward proposals to extend existing smoking legislation in the UK to include vapour from electronic cigarettes. [154218]
Anna Soubry: While they contain nicotine, the majority of electronic cigarettes do not contain tobacco and so legislation that deals with tobacco does not apply.
The Government have no plans to extend the current smokefree legislation. Smokefree legislation regulates being in possession of any lit substance in a form in which it could be smoked, regardless of whether it contains tobacco. Electronic cigarettes that are not lit and operate by creating a vapour would not be covered by the legislation. More research is needed to understand whether there are any risks to health associated with secondhand vapour from e-cigarettes.
To gain a better understanding and inform future policy decisions on e-cigarettes, the Medicines and Healthcare products Regulatory Agency is co-ordinating a period of scientific and market research. The Department will use the information to consider how public health can be protected and promoted.
Meanwhile, we encourage smokers to use licensed nicotine replacement therapy such as patches, gum, inhalators, lozenges or mouth sprays, as the safest source of nicotine, in place of smoking.
Enfield
Nick de Bois: To ask the Secretary of State for Health how much funding (a) his Department and (b) each of the non-departmental public bodies for which he is responsible has allocated to the London borough of Enfield local authority in each of the last five years. [154516]
Anna Soubry: The funding given to each council under each yearly Local Government Finance Settlement is available online at:
www.local.communities.gov.uk/
In addition, the Department of Health has provided a number of grants and transfers to Enfield.
In 2009-10, the Department provided a number of grants to Enfield for social care, totalling over £7.75 million. In 2010-11, the amount awarded to Enfield rose to over £8.4 million.
From 2011-12, the majority of these grants were rolled into the Local Government Finance Settlement. However, local authorities took on a number of new
15 May 2013 : Column 304W
responsibilities for social care, including for the commissioning of services for people with learning disabilities. Enfield also received a transfer from the national health service for social care with a health benefit, resulting in total funding of just over £9 million.
In 2012-13, these funding streams continued, and Enfield again received over £9 million in departmental funding.
For 2013-14, most of the former departmental grant money is to be allocated through the Department for Communities and Local Government's Business Rates Retention scheme. However, local authorities will take on responsibility for public health commissioning and the NHS will continue to transfer funding for social care with a health benefit. In total, Enfield will receive over £18.5 million from the Department in 2013-14.
Flour: Additives
Peter Luff: To ask the Secretary of State for Health (1) what assessment he has made of the effects of the mandatory fortification of bread and flour with key nutrients on individuals' health; [154457]
(2) what assessment he has made of the effects of the fortification of bread and flour with key nutrients on the health of low income groups. [154458]
Anna Soubry: Since 1 April 2013, Public Health England became responsible for Nutrition Science including functions relating to the Scientific Advisory Committee on Nutrition (SACN).
During 2012, SACN conducted an assessment of the effect of removing the nutrients (iron, calcium, thiamin and niacin), which are currently added to bread and flour under the Bread and Flour Regulations.
SACN concluded that without flour fortification the proportion of the population with inadequate intakes of these nutrients would increase, particularly so in relation to calcium and iron intakes in children, older girls and young adult population groups and that this may impact on health. The impact in low income groups is likely to be greater as these groups tend to have lower intakes of these nutrients and consume more bread than compared with the general population.
Prior to this in 2009, SACN had provided the Department with updated advice on the issue of folic acid, concluding that fortification of flour with folic acid would reduce the risk of pregnancies affected by neural tube defects.
Peter Luff: To ask the Secretary of State for Health (1) what assessment he has made of the report of the Scientific Advisory Committee on Nutrition on the potential nutritional effects of repealing the Bread and Flour Regulations 1998; [154459]
(2) what assessment he has made of the potential effects of repealing the Bread and Flour Regulations 1998 on the National Health Service. [154460]
Chris Williamson: To ask the Secretary of State for Health what assessment he has made of the potential effect on (a) public health and (b) the cost of health services arising from revocation of the Bread and Flour Regulations 1998. [154745]
15 May 2013 : Column 305W
Anna Soubry: The Department of Health asked the Scientific Advisory Committee on Nutrition (SACN) to conduct an assessment of the effects on nutritional status of removing the nutrients (iron, calcium, thiamin and niacin), which are currently added to bread and flour under the Bread and Flour Regulations.
SACN's assessment established that without flour fortification the proportion of the population with inadequate intakes of these nutrients would increase, particularly so in relation to calcium and iron intakes in children, older girls and young adult population groups and that this could impact on health. The impact in low income groups is likely to be greater as these groups tend to have lower intakes of these nutrients and consume more bread than compared with the general population.
There is limited information about the effect of repeal on the national health service. Any potential changes to the current nutritional status of particularly vulnerable groups of the population as a result of repeal would require mitigation through ongoing advice on balanced diets and consideration of targeted advice at a local level.
The Department will be working with the Department for Environment, Food and Rural Affairs to ensure that all relevant available evidence is considered as part of deliberations on the recent public consultation on repeal of the Bread and Flour Regulations.
Health Services
Jeremy Lefroy: To ask the Secretary of State for Health what estimate he has made of savings to his Department's budget in 2013-14 as a result of the abolition of strategic health authorities and primary care trusts. [154899]
Dr Poulter: The revised impact assessment for the Health and Social Care Bill (now the Health and Social Care Act 2012) published in September 2011, set out a revised trajectory of how the Department planned to implement the required one-third reduction in total administration costs over the period 2010-11 to 2014-15.
The total administration budget set for 2013-14 is £3,167 million, which is £386 million lower than the estimate in the impact assessment. As savings are measured at total administration cost level, it is not possible to specifically attribute a figure to the abolition of strategic health authorities and primary care trusts.
Jeremy Lefroy: To ask the Secretary of State for Health what estimate he has made of savings accrued to his Department as a result of the reduction in size of strategic health authorities and primary care trusts in each year since 2010-11. [154900]
Dr Poulter: The revised impact assessment for the Health and Social Care Bill (now the Health and Social Care Act 2012), published in September 2011, set out a revised trajectory of how the Department planned to implement the required one-third reduction in total administration costs over the period 2010-11 to 2014-15.
Out-turn for administration costs published in Notes Six and Seven of the Department's annual report and accounts 2011-12 was £3,307 million, which is £662 million lower than the estimate in the impact assessment. The administration out-turn for 2012-13 will be published in the 2012-13 annual report and accounts in July 2013.
15 May 2013 : Column 306W
Health Services: EU Nationals
Philip Davies: To ask the Secretary of State for Health what estimate his Department has made of the additional cost to the NHS as a result of use by Romanian and Bulgarian nationals over the next three years. [154413]
Anna Soubry: The Department has not made an assessment of such additional costs to the national health service.
The United Kingdom can claim back the cost of treating European Economic Area (EEA) nationals visiting or studying in the United Kingdom and for providing healthcare to EEA pensioners who reside here, from their home member state. However we will be consulting in the summer on how the NHS can become more effective at identifying those who are not entitled to free healthcare and claiming money back from them.
EEA nationals working, and paying taxes here, are entitled to free NHS hospital treatment.
Health Services: West Midlands
Paul Farrelly: To ask the Secretary of State for Health (1) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult congenital heart disease services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (i) being treated by such services and (ii) expected to be treated by such services in the financial year 2013-14 in each such area; [154320]
(2) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult highly specialist respiratory services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (i) being treated by such services and (ii) expected to be treated by such services in the financial year 2013-14 in each such area; [154321]
(3) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult highly specialist pain management services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (i) being created by such services and (ii) expected to be treated by such services in the financial year 2013-14 in each such area; [154322]
(4) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult highly specialist rheumatology services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients
15 May 2013 : Column 307W
(i) being treated by such services and (ii) expected to be treated by such services in the financial year 2013-14 in each such area; [154323]
(5) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist vascular services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (i) being treated by such services and (ii) expected to be treated by such services in the financial year 2013-14 in each such area; [154324]
(6) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) what budget he has for the commissioning of specialised services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent, and (vi) South Staffordshire in the year ending 31 March 2014, (b) what the budget was in each such area for the year ending 31 March 2013 and (c) what the budget was per head of population in each such area in each financial year; [154328]
(7) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget he plans to set for the commissioning of adult ataxia telangiectasia services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (i) being treated and (ii) expected to be treated by such services in financial year 2013-14 in each such area; [154339]
(8) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of Barth syndrome services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ended 31 March 2014 and (b) the number of patients (i) receiving treatment and (ii) for which treatment has been budgeted in that year for each such area; [154340]
(9) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of Behcet's syndrome services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ended 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year for each such area; [154341]
(10) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of Bardet-Biedl syndrome services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (i) receiving treatment and (ii) for which treatment has been budgeted in that year for each such area; [154342]
15 May 2013 : Column 308W
(11) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of autologous intestinal reconstruction services for adults in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154343]
(12) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of Alstrom syndrome services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154344]
(13) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of alkaptonuria services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154345]
(14) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult thoracic services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154346]
(15) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist services for patients infected with HIV in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154347]
(16) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist renal services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154348]
(17) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist orthopaedic services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii)
15 May 2013 : Column 309W
Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and
(b)
the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154349]
(18) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of Beckwith-Wiedemann syndrome with macroglossia services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154350]
(19) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist pulmonary hypertension services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154351]
(20) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist opthalmology services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154352]
(21) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist neurosciences services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154353]
(22) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist intestinal failure services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154354]
(23) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist endocrinology services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154355]
15 May 2013 : Column 310W
(24) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist eating disorder services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154356]
(25) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of adult specialist cardiac services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154357]
(26) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of ataxia telengiectasia services for children in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area; [154358]
(27) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) his anticipated budget for the commissioning of autoimmune paediatric gut syndromes services in (i) Shropshire and Staffordshire NHS area, (ii) Shropshire, (iii) Staffordshire, (iv) North Staffordshire, (v) Stoke-on-Trent and (vi) South Staffordshire for the year ending 31 March 2014 and (b) the number of patients (A) receiving treatment and (B) for which treatment has been budgeted in that year in each such area. [154359]
Anna Soubry: The Shropshire and Staffordshire area team does not hold a budget for specialised commissioning.
NHS England is responsible for commissioning specialised services. The prime objective of NHS England is to drive improvement in the quality of the NHS services, and the Government will hold them to account for this through the NHS Mandate.
NHS England is implementing a single operating model for the commissioning of 143 specialised services. This replaces the previous arrangements whereby 10 regional organisations were responsible for commissioning specialised services and where there was wide variation in the range, quality and access to specialised services that were commissioned.
Single nationally agreed service specifications are being developed for each of the 143 services to ensure that patients have equitable access to high quality services, regardless of where they live in England.
Paul Farrelly:
To ask the Secretary of State for Health if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish (a) the administration budget for the Shropshire and
15 May 2013 : Column 311W
Staffordshire NHS Area Team for the year ending 31 March 2014 and
(b)
the number of staff in that team. [154325]
Anna Soubry: NHS England advise me that the full administration budget for the NHS England Shropshire and Staffordshire Area Team has not yet been finalised. However, they also advise that the pay budget has been set at £4.6 million, excluding Family Health Services staff. There are 74.5 full-time equivalent staff in the team, excluding Family Health Services staff.
Paul Farrelly: To ask the Secretary of State for Health if he will direct the Area Director of NHS England in Shropshire and Staffordshire to (a) publish the current eligibility criteria for bariatric surgery in Shropshire and Staffordshire NHS area; and (b) state whether there are any differences in such criteria in any of the sub-areas governed by different clinical commissioning groups in that NHS area. [154326]
Anna Soubry: NHS England is now responsible for commissioning severe and complex obesity services including surgery. NHS. England's 'Clinical Commissioning Policy on Complex and Specialised Obesity Surgery' states that it will commission complex and specialised surgery as a treatment for selected patients with severe and complex obesity that have not responded to all other non-invasive therapies, in accordance with the criteria outlined in this policy.
‘Clinical Commissioning Policy on Complex and Specialised Obesity Surgery’ has been placed in the Library.
Health: Unemployment
Chris Ruane: To ask the Secretary of State for Health what assessment he has made of the effects of unemployment on levels of wellbeing. [154616]
Norman Lamb: Evidence shows that work is generally good for health and good for people who have mental health conditions. Returning to work can be therapeutic and can address the adverse health effects of unemployment.
Employment is an important determinant of mental health and wellbeing and is an important factor in improving the quality of life for people with mental health problems.
The Department for Work and Pensions recently published the National Study of Work-search and Wellbeing, a large-scale study on the extent of mental health conditions among claimants of jobseeker's allowance. This showed that more than one in five people who claimed jobseeker's allowance for six months had a common mental health condition compared with one in six of those who moved off jobseeker's allowance before six months. Evidence published as part of the study also shows that the likelihood of having a common mental health condition increased with the number of years out of work.
Heart Diseases
Chris Ruane: To ask the Secretary of State for Health how many out-of-hospital cardiac arrests occurred in each of the last 30 years; and what the survival rates were of such cardiac arrests in (a) England and (b) each local authority area in England in each such year. [154805]
15 May 2013 : Column 312W
Anna Soubry: This information is not collected centrally.
In the “Cardiovascular Disease Outcomes Strategy”, published in March 2013 an estimate was made that about 50,000 out of hospital cardiac arrests occur each year in England. The overall average rate of survival to hospital discharge was estimated to be 7%. This figure reflects the fact that resuscitation is not always possible following a cardiac arrest.
Herbal Medicine
Michael Ellis: To ask the Secretary of State for Health what progress he has made on implementing a statutory register of herbal medicine practitioners; and when he expects such a register to be in place. [154728]
Dr Poulter: The legislation around this policy is complex and there are a number of issues that have arisen which we need to work through. We appreciate that the delay in going out to consult on this matter is causing concern, however it is important that any new legislation is proportionate and fit for purpose.
The Department intends to make an announcement on the progress of this policy shortly.
In Vitro Fertilisation: West Midlands
Paul Farrelly: To ask the Secretary of State for Health (1) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients whose applications for treatment by in vitro fertilisation and related fertility services had previously been refused received treatment funded by North Staffordshire PCT in the year ending 31 March 2013; [154329]
(2) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of (a) patients and (b) GPs whose applications for in vitro fertilisation treatment had previously been refused were contacted by (i) North Staffordshire PCT or (ii) North Staffordshire Clinical Commissioning Group following the adoption of the new Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria; [154330]
(3) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the amount that was (a) budgeted and (b) spent on in vitro fertilisation and associated fertility services by (i) North Staffordshire PCT, (ii) Stoke-on-Trent PCT and (iii) South Staffordshire PCT in the financial year ending 31 March (A) 2010, (B) 2011, (C) 2012 and (D) 2013 to date; [154331]
(4) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of appeals made under the exceptionality procedures by patients whose applications for in vitro fertilisation treatment were refused by (a) North Staffordshire PCT, (b) Stoke-on-Trent PCT and (c) South Staffordshire PCT in the financial year ending 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013; and to publish the number of such appeals to each such body in each such year which were successful; [154332]
(5) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients whose applications for intracytoplasmic sperm injection treatment were
15 May 2013 : Column 313W
refused by
(a)
North Staffordshire PCT,
(b)
Stoke-on-Trent PCT and
(c)
South Staffordshire PCT in the financial year ended 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013; [154333]
(6) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients whose applications for inter uterine insemination treatment were refused by (a) North Staffordshire PCT, (b) Stoke-on-Trent PCT and (c) Staffordshire PCT in the financial year ended 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013; [154334]
(7) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients whose applications for in vitro fertilisation treatment were refused by (a) North Staffordshire PCT, (b) Stoke-on-Trent PCT and (c) Staffordshire PCT in the financial year ended 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013; [154335]
(8) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients who received intra-uterine insemination treatment through (a) North Staffordshire PCT, (b) Stoke-on-Trent PCT and (c) South Staffordshire PCT in the financial year ended 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013; [154336]
(9) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients who received intracytoplasmic sperm injection treatment through (a) North
15 May 2013 : Column 314W
Staffordshire PCT,
(b)
Stoke-on-Trent PCT and
(c)
South Staffordshire PCT in the financial year ended 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013; [154337]
(10) if he will direct the Area Director of NHS England in Shropshire and Staffordshire to publish the number of patients who received in vitro fertilisation treatment through (a) North Staffordshire PCT, (b) Stoke-on-Trent PCT and (c) South Staffordshire PCT in the financial year ended 31 March (i) 2010, (ii) 2011, (iii) 2012 and (iv) 2013. [154338]
Anna Soubry: We have no plans to direct NHS England to publish the information requested. We understand that the NHS England Area Director for Shropshire and Staffordshire has written to local hon. Members about the new commissioning arrangements for health care.
Kidneys
Mr Amess: To ask the Secretary of State for Health what the mortality rates in hospital as a result of acute kidney injury were in the latest period for which figures are available. [154072]
Anna Soubry: This information is not available in the format requested. Information concerning the number of finished admission episodes (FAEs) with a primary or secondary diagnosis of acute renal failure and acute kidney injury according to whether they were alive or dead at the end of the hospital spell for 2011-12 has been placed in the following table.
| A count of finished admission episodes(1 )with a primary or secondary diagnosis(2) of acute renal failure and acute kidney injury(3) according to whether they were alive or dead(4) at the end of the hospital spell(5) for 2011-12 | |||
| Status of patients at end of spell | |||
| Primary or secondary diagnosis | Alive | Dead | Unknown |
| (1) An FAE is the first period of inpatient care under one consultant within one healthcare provider. FAEs are counted against the year in which the admission episode finishes. Admissions do not represent the number of in-patients, as a person may have more than one admission within the year. (2) The number of episodes where this diagnosis was recorded in any of the 20 (14 from 2002-03 to 2006-07 and seven prior to 2002-03) primary and secondary .diagnosis fields in a Hospital Episode Statistics (HES) record. Each episode is only counted once, even if the diagnosis is recorded in more than one diagnosis field of the record. (3) Acute Renal Failure/Acute Kidney Injury ICD10 codes N17.0 Acute renal failure with tubular necrosis N17.1 Acute renal failure with acute cortical necrosis N17.2 Acute renal failure with medullary necrosis N17.8 Other acute renal failure N17.9 Acute renal failure, unspecified O90.4 Postpartum acute renal failure S37.0 Injury of kidney (4) HES data cannot be used to determine the cause of death of a patient while in hospital. Deaths may be analysed by the main diagnosis for which the patient was being treated but this may not be the underlying cause of death. For example, a patient admitted for a hernia operation (with a primary diagnosis of hernia) may die from an unrelated heart attack. The Office for National Statistics collects information on the cause of death, wherever it occurs, based on the death certificate and should be the source of data for analyses on cause of death. (5) This field contains a code which defines the circumstances under which a patient left hospital. For the majority of patients this is when they are discharged by the consultant. This field is only completed for the last episode in a spell. Alive: Discharged on clinical advice or with clinical consent Self discharged, or discharged by a relative or advocate Discharged by a mental health review tribunal, the Secretary of State for the Home Department or a court Dead: Died Baby was still born Unknown: Not known—a validation error Source: Hospital Episode Statistics (HES), Health and Social Care Information Centre. Activity in English NHS Hospitals and English NHS commissioned activity in the independent sector. | |||
15 May 2013 : Column 315W
Mr Amess: To ask the Secretary of State for Health what steps he plans to take to support the implementation of the forthcoming clinical guideline on acute kidney injury to be published by the National Institute for Health and Clinical Excellence in 2013. [154171]
Norman Lamb: The National Institute for Health and Care Excellence (NICE) currently expects to publish its clinical guideline on the prevention, detection and management of acute kidney injury up to the point of renal replacement therapy in August 2013.
NHS England and NICE share the objectives of facilitating high quality care and improved outcomes for patients, while guiding practitioners and those who support them in delivering effective and cost effective care. The two organisations have a partnership agreement in place and will work together to enhance the dissemination and adoption of NICE guidance and quality standards.
For instance, NHS England may provide and publish benchmarking information to help local systems understand their current performance and both organisations can make available a range of tools to support the commissioning and implementation process.
Mental Illness: Surveys
Chris Ruane: To ask the Secretary of State for Health when the next adult psychiatric morbidity survey will be completed. [154228]
Norman Lamb: The Department and the Health and Social Care Information Centre are currently discussing plans for the next survey, which should take place in 2014.
Mental Illness: Veterans
Jim Sheridan: To ask the Secretary of State for Health what recent discussions he has had with his Scottish counterparts on strategies to (a) prevent and (b) alleviate mental health issues among veterans. [154767]
Dr Poulter: Department of Health officials work closely with their Scottish, Welsh and Northern Irish counterparts through the Ministry of Defence/UK Departments of Health Partnership Board that meets regularly. The board agrees how to tackle health issues for serving members of the armed forces and veterans across the UK. Following the report by Dr Murrison ‘Fighting Fit’ departmental officials have been in regular contact with those from Scotland to discuss the veterans' mental health recommendations made by Dr Murrison.
Services funded by the Department in response to Dr Murrison's report to help tackle mental health issues amongst veterans include Big White Wall—an on-line counselling service. The Department and Ministry of Defence fund this service (with additional funding from Help for Heroes) for those currently serving, veterans and their respective families. More than 2,400 are using this service. Working with Combat Stress and Rethink the Department has also put in place a 24-hour veterans' mental health helpline. Both of these initiatives are available to those outside of England, including Scottish veterans and their families.
15 May 2013 : Column 316W
North Tees and Hartlepool NHS Foundation Trust
Mr Iain Wright: To ask the Secretary of State for Health what information he holds on the cost of treating foreign nationals at North Tees and Hartlepool NHS Foundation Trust in each of the last four years. [155199]
Anna Soubry: The Department does not hold information on costs incurred by the North Tees and Hartlepool NHS Foundation Trust through treating overseas visitors in the years given.
Information on debts written off in relation to overseas visitors may be available from the Foundation Trust direct. However, it should be noted that data relating to overseas visitors might include United Kingdom nationals visiting from overseas as well as foreign nationals who are either visiting the UK or residing here without permission. In addition, the true cost to the national health service is not limited to the debts the NHS has to absorb but also the cost of treating those overseas visitors, including foreign nationals, who are exempt from charge under regulations and so funded by commissioners, and the provision of free primary care to all overseas visitors.
Organs
Kate Green: To ask the Secretary of State for Health (1) what his policy is on organ allocation; [154208]
(2) what assessment he has made of variations in organ allocation policies across NHS trusts in England and Wales. [154275]
Anna Soubry: The organ allocation system in place works on a United Kingdom-wide basis. It ensures that patients are treated equitably and that donated organs are allocated in a fair and unbiased way. The offering process for organs donated in the UK is specified in NHS Directions given to NHS Blood and Transplant by the Secretary of State for Health, specifically in paragraph four of the NHS Blood and Transplant (2005) Directions and associated guidance. (The Directions can be found at:
www.organdonation.nhs.uk
then enter search item “2005 Directions” and click on the first result). The allocation schemes have been developed by the medical profession in consultation with the Department and specialist advisory groups and there are specific allocation systems in place for each type of organ.
It is the remit of NHS Blood and Transplant, as the national retrieval and allocation organisation for the UK, to offer organs for transplant. Organs from deceased donors in the UK are considered a national resource.
The schemes prioritise patients with the most urgent need and also take into account factors which influence the chances of a successful transplant, including the age of the donor and recipient, blood and tissue type, physical characteristics (such as height and weight) and the location of the recipient relative to the donor. Transplants are more likely to be successful if undertaken as quickly as possible after retrieval.
Kate Green: To ask the Secretary of State for Health (1) what estimate he has made of the proportion of hospital trusts that receive donated organs which allocate donor organs to other trusts; [154212]
15 May 2013 : Column 317W
(2) what procedures are in place to enable foundation trusts to (a) offer and (b) access donated organs from other foundation trusts. [154274]
Anna Soubry: No estimate has been made of the proportion of hospital trusts that receive donated organs which allocate organs to other trusts.
The allocation system in place works on a United Kingdom-wide basis and whether a trust is a foundation trust or otherwise has no bearing. There are 28 hospitals in the UK that are licensed to perform solid organ transplants and some of these hospitals transplant more than one type of organ. Organs for transplant in these hospitals are retrieved from over 200 hospitals throughout the UK.
The allocation systems in place ensure that patients are treated equitably and that donated organs are allocated in a fair and unbiased way. It is the remit of NHS Blood and Transplant, as the national retrieval and allocation organisation for the UK, to offer organs for transplant in line with directions given to them by the Secretary of State for Health.
Organs: Scotland
Cathy Jamieson: To ask the Secretary of State for Health what recent discussions he has had with the Cabinet Secretary for Health in the Scottish Government regarding cross-border organ allocation. [154426]
Anna Soubry: No discussions have taken place with the Cabinet Secretary for Health in the Scottish Government regarding cross-border organ allocation.
The organ allocation system in place works on a United Kingdom-wide basis and organs are regularly transported within the UK. This ensures that patients are treated equitably and that donated organs are allocated in a fair and unbiased way based on the patient's need, and the importance of achieving the closest possible match between donor and recipient. The rules for allocating organs donated in the UK are determined by the medical profession in consultation with other health professionals, the Department and specialist advisory groups. The offering process is specified in NHS Directions given to NHS Blood and Transplant by the Secretary of State for Health, specifically in paragraph four of the NHS Blood and Transplant (2005) Directions and associated guidance.
Pay
Priti Patel:
To ask the Secretary of State for Health what guidance his Department issues on the actions that would result in the suspension or removal of a bonus payment to an official in his Department; what
15 May 2013 : Column 318W
the process is for clawing back such bonuses; and on how many occasions this has happened in each of the last five years. [154999]
Dr Poulter: The Department does not issue specific guidance on the actions that would result in the suspension or removal of a bonus payment for an official.
However the withdrawal or withholding of performance related pay (which includes nonconsolidated performance related payments) is a potential sanction in disciplinary proceedings.
In the last five years the Department has not removed or suspended any non consolidated performance related payments to its officials.
Publications
Ann McKechin: To ask the Secretary of State for Health how much his Department spent on subscriptions to academic journals published by (a) Reed-Elsevier, (b) Wiley-Blackwell, (c) Springer and (d) any other academic publisher in each of the last five years. [154496]
Dr Poulter: The Department's spend on academic journals over the last five years is as follows (given as calendar years to align with subscriptions). Answers are given for any and all known imprints of the requested publishers.
| £ | |||||
| 2009 | 2010 | 2011 | 2012 | 2013 | |
Transplant Surgery: Waiting Lists
Kate Green: To ask the Secretary of State for Health what estimate he has made of the (a) number and (b) proportion of people on waiting lists who receive organ transplants in (i) North West England, (ii) Stretford and Urmston constituency and (iii) England. [154276]
Anna Soubry: The information can be found in the following table. Care should be taken when interpreting percentages based on small numbers.
Although no period of time is specified in the question, figures in the table cover new registrations over a three year period 2008-09 to 2010-11. This is because numbers of registrations and transplants for the Stretford and Urmston constituency are low and looking at a three year period allows for meaningful comparisons to be drawn.
| Number of new registrants to the organ donor waiting list and transplants in North West England, Stretford and Urmston and England by organ in 2008-11 | ||||
| Organ | Strategic health authority area | New registrations(1) | Transplants(2) | Proportion(3) (percentage) |
15 May 2013 : Column 319W
15 May 2013 : Column 320W
| (1) New registrations to the organ donor waiting list between 1 April 2008 and 31 March 2011. (2) Transplants which took place between 1 April 2008 and 31 March 2011. (3) Not all of the transplants that took place in the period will have been for people who were added to the waiting list in that period, additionally some people who were added to the waiting list during the period will have had transplants after. (4)( )Kidney only registrations (5) Pancreas only and kidney/pancreas registrations (6) Heart only transplants (7) Lung only transplants (8) Liver only transplants Source: NHS Blood and Transplant | ||||
Kate Green: To ask the Secretary of State for Health what proportion of patients on an organ transplant waiting list in each region of England waited more than (a) six months, (b) 12 months and (c) 18 months for each type of organ transplanted in the latest period for which figures are available. [154277]
Anna Soubry: The information requested can be found in the following table. Care should be taken when interpreting percentages based on small numbers.
| Table: Patients registered on the United Kingdom organ transplant list waiting six, 12 and 18 months for an organ transplant by organ and English region, 1 April 2008 to 31 March 2011 | ||||||||
| Strategic health authority area(1) | New registrations | Still waiting six months(1) | Still waiting 12 months(1) | Still waiting at 18 months(1) | ||||
| No. | % | No. | % | No. | % | |||
15 May 2013 : Column 321W
15 May 2013 : Column 322W
| (1 )Regions are based on strategic health authority areas (2 )Kidney only registrations (3 )Pancreas only and kidney/pancreas registrations (4 )Heart only transplants (5 )Lung only transplants (6 )Liver only transplants Source: NHS Blood and Transplant | ||||||||